Raising The Quality Standard

Legacy Cancer Institute delivers exceptional breast cancer care.

Services > Adult Services A-Z > Cancer > Recently Diagnosed > Breast Cancer > Raising The Quality Standard

Meet our providers

To schedule an appointment at Legacy Cancer Institute, give us a call or learn more about our breast cancer care team
503-413-5525  (Oregon)  
360-487-1020  (Washington)

Raising quality care doctor with patient

How our program compares

Our breast cancer program is among the top in the nation when measured by our quality of care. We not only meet or exceed our peers in the region, but we often better than national averages in terms of providing recognized standards of cancer care. Our performance in these accreditation programs tells you that we provide the highest level of care cancer available.

The numbers tell the story

Through a review process from independent groups, the quality of our breast cancer program is measured against standards developed by national experts. The results show how often Legacy Cancer Institute meets or exceeds our peers in reaching the ultimate target goal of 100 percent.

Chemotherapy for hormone receptor negative breast cancer among the top 5% nationally

  • Legacy Health: 98.18%
  • Nationwide: 90.68%
  • Oregon: 96.67%
  • Washington: 92.73%


Quality measure details: Combination chemotherapy or chemo-immunotherapy (if HER2 positive) is recommended or administered within 4 months (120 days) of diagnosis for women under 70 with AJCC T1cN0M0, or stage IB - III hormone receptor negative breast cancer.


Radiation therapy after breast conserving surgery

  • Legacy Health: 91.43%
  • Nationwide: 91.22%
  • Oregon: 92.34%
  • Washington: 93.68%%

Quality measure details: Radiation therapy is administered within one year of diagnosis for women under age 70 receiving breast-conserving surgery for breast cancer. 

 


  • Legacy Health: 83.09%
  • Nationwide: 83.27%
  • Oregon: 85.85%
  • Washington: 81.73%

Quality measure details: First therapeutic breast surgery in a non-neoadjuvant setting is performed within 60 days of diagnosis for patients with AJCC clinical stage I-III breast cancer.


The most recent American College of Surgeons Commission on Cancer quality indicators, showing how Legacy ranks against our peers. Table shows the proportion of breast cancer patients treated according to nationally recognized standards of care. Data is the most recent available, 2020. 

More support

You are not alone. Legacy offers support throughout your cancer journey, as well as care for your emotional, social and spiritual needs.

Nurse navigators
Legacy Cancer Healing Center 
Support groups and classes
Cancer rehabilitation 
Survivorship services

Meet our providers

To schedule an appointment at Legacy Cancer Institute, give us a call or learn more about our breast cancer care team
503-413-5525  (Oregon)  
360-487-1020  (Washington)